Novavax's protein-based shot is an option for COVID vaccination this season, joining refreshed formulas from Moderna and ...

Shares of Novavax Inc. NVAX shed 5.62% to $13.61 Friday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP rising 1.22% to ...

On Thursday, Novavax Inc (NVAX) stock saw a decline, ending the day at $14.42 which represents a decrease of $-0.26 or -1.77% from the prior close of $14.68. The stock opened at $14.07 and touched a ...

Novavax (NVAX) concluded the recent trading session at $14.42, signifying a -1.77% move from its prior day's close.

The federal government's decision to not provide Novavax's COVID-19 vaccine this respiratory virus season raises health equity concerns, experts and advocates say.

Shares of Levi Strauss & Co. (LEVI) are tumbling after the company slightly missed third quarter revenue expectations and ...

Novavax (NVAX) stock fell after a clarification on an analyst report led to a sharp rally in the company stock in the ...

Novavax (NVAX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...

With cold and flu season ramping up some Canadians have been travelling south of the border and paying hundreds of dollars to ...